2 weeks Ago By Defense World Staff
Alliance Global Partners started coverage on shares of GeoVax Labs ( NASDAQ:GOVX – Get Free Report ) in a report issued on Monday, MarketBeat.com reports. The firm set a “buy” rating and a $15.
00 price target on the stock. Alliance Global Partners’ price objective suggests a potential upside of 361.54% from the company’s current price.
Other research analysts also recently issued reports about the company. Roth Capital raised GeoVax Labs to a “strong-buy” rating in a research report on Tuesday, July 16th. EF Hutton Acquisition Co.
I upgraded shares of GeoVax Labs to a “strong-buy” rating in a research report on Tuesday, July 23rd. Roth Mkm initiated coverage on shares of GeoVax Labs in a research report on Tuesday, July 16th. They set a “buy” rating and a $20.
00 price target on the stock. Noble Financial raised their price target on GeoVax Labs from $6.00 to $10.
00 and gave the company an “outperform” rating in a report on Monday, August 19th. Finally, HC Wainwright reiterated a “buy” rating and set a $8.00 target price on shares of GeoVax Labs in a research report on Monday, August 12th.
Four analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Buy” and an average price target of $13.25.
Read Our Latest Stock Report on GeoVax Labs GeoVax Labs Stock Performance About GeoVax Labs ( Get Free Report ) GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. Featured Stories Five stocks we like better than GeoVax Labs Low PE Growth Stocks: Unlocking Investment Opportunities Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025 Why Understanding Call Option Volume is Essential to Successful Options Trading Is Tesla’s Valuation a Bubble or Backed by Real Growth? How Can Investors Benefit From After-Hours Trading Trucking Stocks Led the Pack Last Week: Can They Keep Rolling? Receive News & Ratings for GeoVax Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeoVax Labs and related companies with MarketBeat.
com's FREE daily email newsletter ..
